Major API supplier Olon is establishing a €10 million central R&D hub at its headquarters site in Roadano, near Milan. The Italian company said the facility paves the way...

ESIM Chemicals provides customers with sophisticated and flexible specialty chemical synthesis outside their own facilities and continuous improvement from the initial...

EureKING, a new special purpose acquisition company (SPAC) steered by former European biopharma executives, launched itself on May 9 and in a subsequent listing on the...

Interview with Giovanna Libralon, Senior Director Commercial Development Small Molecules at Lonza.

Germany’s Merck has signed a definitive agreement to acquire Exelead, a US biopharmaceutical CDMO, for around $780 million in cash. The Indianapolis, Indiana-based...

Contract development and manufacturing organization (CDMO) CordenPharma has announced the completion of a Phase 1 strategic investment to create a Flow Chemistry Centre...

French CDMO GTP Bioways, a specialist in biotherapies and nanotherapies, is investing €12 million in two new biopharmaceutical production lines at its site in Toulouse...

Avid Bioservices, a biologics-oriented CDMO based in the US state of California, is building a new plant in Costa Mesa, California, as part of a plan to expand its cell...